[Pregnancy and antiphospholipid syndrome].

Area of Science:

• Obstetrics and Gynecology
• Hematology
• Immunology

Context:

• Antiphospholipid syndrome (APS) poses significant risks for obstetrical complications, impacting both maternal and fetal health.
• Obstetric APS is characterized by specific pregnancy complications, including recurrent miscarriages, intrauterine fetal death, and premature birth due to severe preeclampsia or placental issues.
• Key risk factors for pregnancy failure in APS include a history of thrombosis and the presence of lupus anticoagulant.

Purpose:

• To outline the definition, risks, and management strategies for obstetric Antiphospholipid syndrome (APS).
• To emphasize the importance of a multidisciplinary approach and preconception counseling for high-risk pregnancies.
• To detail current treatment recommendations, including heparin and low-dose aspirin, and postpartum monitoring.

Summary:

• Obstetric APS pregnancies face elevated risks of placental abruption, HELLP syndrome, and thrombosis.
• A multidisciplinary team, preconception counseling, and tailored treatments (heparin, aspirin) are crucial.
• Postpartum monitoring and antithrombotic coverage are necessary due to persistent maternal risks.
• Doppler ultrasound findings, specifically persistent notches, are predictive of placental vascular complications.

Impact:

• Multidisciplinary antenatal care and optimized treatment significantly improve pregnancy outcomes in women with obstetric APS.
• Early identification and management of risks associated with APS can lead to more favorable maternal and fetal results.
• This approach aims to minimize complications and ensure the best possible prognosis for these high-risk pregnancies.